Point72 Asset Management’s Relmada Therapeutics RLMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-250,000
| Closed | -$1.04M | – | 1808 |
|
|
2023
Q4 | $1.04M | Buy |
+250,000
| New | +$1.04M | ﹤0.01% | 915 |
|
|
2023
Q3 | – | Sell |
-4,703
| Closed | -$11.6K | – | 2106 |
|
|
2023
Q2 | $11.6K | Buy |
+4,703
| New | +$11.6K | ﹤0.01% | 1357 |
|
|
2022
Q4 | – | Sell |
-837,190
| Closed | -$31M | – | 1367 |
|
|
2022
Q3 | $31M | Sell |
837,190
-435,384
| -34% | -$16.1M | 0.12% | 211 |
|
|
2022
Q2 | $24.2M | Sell |
1,272,574
-39,826
| -3% | -$756K | 0.1% | 258 |
|
|
2022
Q1 | $35.4M | Buy |
1,312,400
+366,087
| +39% | +$9.88M | 0.14% | 179 |
|
|
2021
Q4 | $21.3M | Buy |
946,313
+726,313
| +330% | +$16.4M | 0.09% | 308 |
|
|
2021
Q3 | $5.77M | Buy |
220,000
+25,490
| +13% | +$668K | 0.03% | 590 |
|
|
2021
Q2 | $6.23M | Buy |
194,510
+22,010
| +13% | +$705K | 0.03% | 526 |
|
|
2021
Q1 | $6.07M | Sell |
172,500
-112,500
| -39% | -$3.96M | 0.03% | 509 |
|
|
2020
Q4 | $9.14M | Buy |
285,000
+85,709
| +43% | +$2.75M | 0.04% | 435 |
|
|
2020
Q3 | $7.5M | Buy |
199,291
+34,732
| +21% | +$1.31M | 0.04% | 443 |
|
|
2020
Q2 | $7.36M | Buy |
+164,559
| New | +$7.36M | 0.05% | 385 |
|
|
2020
Q1 | – | Sell |
-136,900
| Closed | -$5.34M | – | 992 |
|
|
2019
Q4 | $5.34M | Buy |
+136,900
| New | +$5.34M | 0.03% | 457 |
|